- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 513/04 - Ortho-condensed systems
Patent holdings for IPC class C07D 513/04
Total number of patents in this class: 4142
10-year publication summary
|
227
|
219
|
270
|
282
|
273
|
252
|
238
|
278
|
286
|
183
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4855 |
89 |
| Merck Patent GmbH | 5768 |
76 |
| F. Hoffmann-La Roche AG | 7947 |
71 |
| Merck Sharp & Dohme LLC | 3757 |
65 |
| Boehringer Ingelheim International GmbH | 4646 |
64 |
| Takeda Pharmaceutical Company Limited | 2706 |
59 |
| Janssen Pharmaceutica N.V. | 3362 |
58 |
| Hoffmann-La Roche Inc. | 3468 |
56 |
| Genentech, Inc. | 4001 |
53 |
| Novartis AG | 10725 |
50 |
| Daiichi Sankyo Company, Limited | 1886 |
50 |
| BASF SE | 20991 |
47 |
| Achillion Pharmaceuticals, Inc. | 164 |
46 |
| Amgen Inc. | 4105 |
43 |
| Gilead Sciences, Inc. | 2049 |
40 |
| Dana-Farber Cancer Institute, Inc. | 2593 |
36 |
| Incyte Corporation | 1024 |
33 |
| Sumitomo Chemical Company, Limited | 9047 |
31 |
| Abbvie Inc. | 1801 |
31 |
| FUJIFILM Corporation | 29586 |
30 |
| Other owners | 3114 |